Company intelligence / Profile preview

Softchina Venture Group

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Softbank China Venture Capital (SBCVC) is a leading venture capital firm established in 2000 that manages multiple USD and RMB funds. The firm focuses on high-growth companies across several key sectors, with healthcare, TMT, and clean technology serving as its primary investment pillars. Within the life sciences domain, SBCVC invests across the entire value chain, including biotechnology, medical devices, diagnostics, and healthcare services. The group is widely recognized for its early-stage investment in Alibaba and has since developed a robust portfolio of innovative healthcare companies in the Greater China region.

Industry: Investors

Beyond the preview

Go deeper on Softchina Venture Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Softchina Venture Group.

Explore the full profile